Ensuring compliance with the False Claims Act has never been more important for healthcare providers.
Governmental personnel and policy changes along with multiple legislative developments at both the state and federal levels have contributed to an unsettled landscape for healthcare providers in 2020. Staying current on recent civil and criminal court rulings, settlements, and directives from the government is critical for Compliance Officers, General Counsels, and other C-suite executives tasked with oversight and administration of healthcare compliance.
Bass, Berry & Sims is pleased to announce the release of the 2019 edition of its Healthcare Fraud & Abuse Annual Review. Compiled by the firm’s Healthcare Fraud Task Force, the Review is an in-depth and comprehensive analysis of enforcement settlements, court decisions, and recent developments affecting the healthcare industry.
The Review details all healthcare-related False Claims Act (FCA) settlements from last year, organized by particular sectors of the healthcare industry. In addition to reviewing all healthcare fraud-related settlements, the Review includes updates on enforcement-related litigation involving the Stark Law and Anti-Kickback Statute (AKS), and looks at the continued implications from the government’s focus on enforcement efforts involving individual actors in connection with civil and criminal healthcare fraud investigations.
The latest Healthcare Fraud & Abuse Review takes a closer look at:
- Issues to watch in 2020
- Noteworthy settlements from 2019
- Comprehensive coverage of significant FCA decisions
- Notable developments involving the Stark Law and AKS
- Discussion of pharmaceutical and medical device risk areas
